Form 10-Q LISATA THERAPEUTICS, For: Jun 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Form 10-Q LISATA THERAPEUTICS, For: Jun 30

H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)

August 13, 2024 6:04 AM EDT

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $15.00 price target on Lisata Therapeutics, Inc (NASDAQ: LSTA).

The analyst comments "Financial and corporate update. Yesterday after the close, Lisata announced 2Q24 financial results, posting EPS of ($0.61) compared to our estimate of ($0.76)... More